FdaApplication
ANDA 212126
Identifiers
- fda_app_no: ANDA212126
Properties
| Property | Value |
|---|---|
| applicant_name | BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD |
| application_type | ANDA |
| approval_date | 2019-09-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENTECAVIR | ENTECAVIR | 0.5MG | TABLET;ORAL |
| ENTECAVIR | ENTECAVIR | 1MG | TABLET;ORAL |
2 products